Online posts claimed Gates donated $50 million to develop RNA-based technology for crops that U.S. regulators had supposedly ...

Orthohantaviruses, such as the Puumala virus, are widespread in Europe, causing flu-like illnesses and severe kidney damage ...

近日，中国科学院分子细胞科学卓越创新中心团队等，开发了检测RNA结合蛋白（RBP）在RNA上结合位点的高灵敏、高信噪比深度测序方法uSpyCLIP，并运用这一技术揭示了两种目前应用最为广泛的Cas13核酸酶——Prevotella sp. P5-125 (Psp)Cas13b和Ruminococcus flavefaciens XPD3002 (Rfx ...

A Veridapt DX test platform aims to help oncologists determine early treatment in whether chemotherapy is effectively destroying a patient's tumour ...

The mechanism of action of mRNA vaccines goes far beyond harnessing host cellular machinery to produce antigenic proteins to spur immunity, write Nicolas Hulscher, M.P.H., Peter A. McCullough, M.D., M ...

More than $1.1 million in new provincial funding is accelerating cancer research in Sudbury, supporting a homegrown technology that could change how oncologists assess chemotherapy effectiveness.

When closely related species mate, their offspring sometimes survive but cannot reproduce. This pattern often affects males ...

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering ...

Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors Proceeds support the achievement of value inflection points for multiple RNA editi ...

The stock was down 14% premarket after BioNTech announced the departures and issued revenue guidance that fell short of Wall Street’s forecasts.

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or "Aptorum”), a clinical stage biopharmaceutical company ...

HONG KONG SAR - Media OutReach Newswire - 10 March 2026 - CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences" or the "Company", Stock Code: 0775) today announced the establishment of ...